ISRCTN37245053已完成不适用
Therapeutic implications of oral hypoglycaemic agents on the enteroinsular axis in type 2 diabetes
Royal Victoria Hospital (UK)0 个研究点目标入组 40 人开始时间: 2008年11月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Both males and females, aged greater than 18 years
- •2. Type 2 diabetes controlled by diet or a single oral hypoglycaemic agent
- •3. HbA1c less than 7.5%
- •4. No significant liver, cardiac or renal problems (creatinine greater than 150 mmol/l)
排除标准
- •Type 2 diabetes on two or more hypoglycaemic agents or requiring insulin.
研究者
相似试验
已完成
不适用
The effectiveness of oral hypoglycemic agents in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus. -Multiple comparison, Dapagliflozin, Pioglitazone vs Glimepirideonalcoholic fatty liver disease patients with type 2 diabetesJPRN-UMIN000021291Kawasaki Medical SchoolKawasaki Medical School Devision of Diabetes, Endocrinology and Metabolism90
招募中
不适用
Study of effect of oral anti-diabetic medication on cognitive function in young and middle-aged type 2 diabetes mellitus patientsCTRI/2020/02/023645Dr Vangaveti Sneha
已完成
不适用
Effective treatment of hypoglycaemia in children with type 1 diabetes: A randomised controlled clinical trialHypoglycaemiaMetabolic and Endocrine - DiabetesACTRN12609000129280Esko Wiltshire160
已完成
不适用
Study of the oral hypoglycemic agent treatment after insulin therapy secessioJPRN-UMIN000009637Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine40
招募中
不适用
Efficacy and safety of hypoglycemic agents in nonalcoholic fatty liver disease with type 2 diabetesJPRN-UMIN000045572ippon Medical School100